Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic epitope tag derived from the influenza hemagglutinin protein, routinely used for tagging recombinant proteins in molecular biology research (A6004 product page). It enables efficient detection and purification of HA-tagged fusion proteins via competitive binding to anti-HA antibodies (Wei et al., 2021). The peptide exhibits high solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL), supporting diverse experimental conditions. Purity exceeding 98% (HPLC/MS) ensures minimal background in immunoprecipitation and elution workflows. Proper storage at -20°C (desiccated) is critical for stability and performance.

Biological Rationale

The HA tag is a nine-amino acid sequence (YPYDVPDYA) originally derived from the human influenza virus hemagglutinin protein. It serves as a highly specific epitope recognized by monoclonal anti-HA antibodies. The HA tag is genetically fused to proteins of interest, facilitating downstream detection, purification, and interaction studies (Wei et al., 2021). Its small size minimizes interference with protein folding and function. The HA tag is well established as a molecular biology tool for protein tracking, immunoprecipitation, and affinity purification workflows. This approach has been central to the study of protein trafficking, post-translational modifications, and protein-protein interaction mapping. The A6004 Influenza Hemagglutinin (HA) Peptide from APExBIO is supplied as a high-purity, synthetic standard for experimental elution and competition assays.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The Influenza Hemagglutinin (HA) Peptide functions as a competitive ligand for anti-HA antibodies. When introduced to immunoprecipitation assays, the free HA peptide competes with HA-tagged fusion proteins bound to immobilized anti-HA antibodies. This competition results in the release (elution) of the tagged protein from the antibody complex (APExBIO product page). The high affinity and specificity of the HA tag-antibody interaction enable selective isolation of fusion proteins with minimal cross-reactivity. The peptide's high solubility in common solvents (e.g., DMSO, ethanol) allows for flexible buffer formulation, ensuring effective elution conditions for diverse protein targets. The synthetic peptide is routinely used for elution following magnetic bead or agarose-based immunoprecipitation of HA-tagged proteins.

Evidence & Benchmarks

• HA peptide enables efficient and specific elution of HA-tagged fusion proteins from anti-HA immunoprecipitates (Wei et al., 2021, https://doi.org/10.1038/s41422-020-00409-1).
• High solubility in water (≥46.2 mg/mL), DMSO (≥55.1 mg/mL), and ethanol (≥100.4 mg/mL) supports multiple buffer systems (APExBIO, product page).
• Pooled HPLC and mass spectrometry analyses confirm purity ≥98%, reducing the risk of contaminating peptides during protein elution (APExBIO).
• Use of HA peptide in protein-protein interaction studies is supported by benchmarking evidence in exosome biogenesis and trafficking pathways (Wei et al., 2021, DOI).
• Competitive elution with synthetic HA peptide preserves protein complexes in native state, critical for downstream analyses such as mass spectrometry (Related article).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is widely used in:

• Immunoprecipitation and competitive elution of HA-tagged proteins.
• Affinity purification and detection in western blotting, ELISA, and immunofluorescence.
• Protein-protein interaction studies, including mapping of protein complexes under native conditions.
• Mechanistic dissection of cellular pathways, such as ubiquitination and trafficking (see advanced applications—this article extends on the mechanistic insights provided there by detailing competitive binding and solubility parameters).

Common Pitfalls or Misconceptions

• The HA peptide does not enable purification of untagged or endogenously expressed proteins lacking the HA epitope.
• Excessive peptide concentrations may result in incomplete elution or antibody saturation; titration is required for optimal yield.
• Long-term storage of peptide solutions (vs. lyophilized form) can reduce stability and elution efficiency (APExBIO).
• Not all anti-HA antibodies have identical affinities; elution conditions may require empirical optimization.
• HA peptide is not suitable for protein detection in native tissues without prior genetic tagging.

Workflow Integration & Parameters

To use the Influenza Hemagglutinin (HA) Peptide (A6004), dissolve in sterile water, DMSO, or ethanol to prepare a 1-10 mM stock solution. For immunoprecipitation elution, add peptide to the bead-antibody-protein complex at a final concentration of 0.2–1 mg/mL, incubate for 30–60 minutes at 4°C, then collect the eluted protein (see benchmarking guide—this article updates storage and solubility data). Store lyophilized peptide desiccated at -20°C; avoid repeated freeze-thaw cycles for solutions. The A6004 product is supplied at >98% purity, ensuring minimal interference in downstream mass spectrometry or biochemical assays. For optimal results, use an anti-HA antibody validated for the application and buffer conditions compatible with both the antibody and the protein of interest.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide (A6004, APExBIO) is a cornerstone reagent for protein detection, purification, and interaction mapping in molecular biology. Its well-characterized sequence, high purity, and robust solubility profile support efficient immunoprecipitation and elution workflows. The competitive binding mechanism ensures selective recovery of HA-tagged proteins while maintaining protein complex integrity for downstream analyses. Ongoing improvements in antibody engineering and tag design are expected to further enhance the specificity and efficiency of HA tag-based workflows. For deeper mechanistic insights and translational applications, researchers are encouraged to consult recent literature and APExBIO's technical documentation. For a comprehensive comparison of HA tag performance and detailed benchmarking, see this resource—the present article clarifies best practices for peptide storage and elution under variable buffer conditions.